XHE
State Street SPDR S&P Health Care Equipment ETF
SPDR S&P Health Care Equipment ETF is an exchange-traded fund incorporated in the USA. The Fund's objective is to replicate as closely as possible the performance of the S&P Health Care Equipment Select Industry Index.
US
EQUITY
Rules-Based
MANAGEMENT STYLE
$ 124.8 M
ASSETS UNDER MGMT
35 bp
EXPENSES
Fund Basics
| Inception date | Jan 26, 2011 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | Yes |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
Complete list +
| STAAR SURGICAL CO | 2.9 % |
| NOVOCURE LIMITED | 2.4 % |
| INTEGRA LIFESCIENCES HOLDING | 2.1 % |
| AXOGEN, INC. | 2.1 % |
| AVANOS MEDICAL, INC. | 2.1 % |
| LANTHEUS HOLDINGS INC | 2.1 % |
| BUTTERFLY NETWORK, INC. CLASS A | 2.1 % |
| LIVANOVA PLC | 2.1 % |
| OMNICELL INC | 2.1 % |
| TELEFLEX INC | 2.0 % |
Constituent Breakdown
| Number of holdings | 64 |
| Herfindahl-Hirschman Index | 170 |
| Wgt avg mkt cap (mns) | $22,809 |
| Large cap (>$10bn) | 35.9% |
| Mid cap ($2-10bn) | 29.6% |
| Small cap (<$2bn) | 32.1% |
| Developed mkts. | 97.3% |
| Emerging mkts. | 0.0% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 89.4 % |
 |
BRITAIN | 4.4 % |
 |
IRELAND | 3.1 % |
Historical Performance
Standardized Performance (as of 05/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | -9.9% | -2.1% | -3.8% | -5.1% | -8.1% | 6.0% | -- | 7.8% |
| Dividend Yield | 0.0% | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% | -- | 0.9% |
| Total Returns | -9.9% | -2.0% | -3.7% | -5.1% | -8.0% | 6.1% | -- | 8.7% | Ann. Volatility | 23.3% | 21.4% | 21.7% | 21.7% | 24.4% | 22.9% | -- | 21.3% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.06 | 34% |
| MSCI EAFE | 0.82 | 33% |
| MSCI Emg Mkts | 0.47 | 19% |
Liquidity Measures
| Avg. volume (000) | 29 |
| ADV traded (mns) | $2 |
| Turnover | 1.8% |
| Avg. Bid/Ask (% of price) | 0.21% |
Technical Indicators
| 30d moving avg. (EMA) | $80.24 |
| Relative strength (RSI) | 47 |
| MACD/Signal | -0.16/-0.30 |
| Bollinger Bands (Upper/Lower) | $82.18/$77.20 |
| Short interest (% of AUM) | 27.4% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. XHE |
Expenses vs. XHE |
ALTAR Score™ vs. XHE |
|---|---|---|---|---|
| MDEV | First Trust Indxx Medical Devices ETF | 36.7% | +35 bp | +1.4% |
| IHI | iShares U.S. Medical Devices ETF | 34.5% | +5 bp | +1.6% |
| HTEC | ROBO Global Healthcare Technology and Innovation ETF | 29.6% | +33 bp | -1.7% |
| RSPH | Invesco S&P 500 Equal Weight Health Care ETF | 24.8% | +5 bp | +3.2% |
| PSCH | Invesco S&P SmallCap Health Care ETF | 20.9% | -6 bp | -1.3% |
| FXH | First Trust Health Care AlphaDEX Fund | 20.6% | +27 bp | +1.6% |
| HEAL | Global X HealthTech ETF | 19.6% | +15 bp | -4.7% |
| FDHT | Fidelity Digital Health ETF | 16.8% | +4 bp | -1.8% |
| EKG | First Trust Nasdaq Lux Digital Health Solutions ETF | 14.5% | +30 bp | -2.9% |
| FHLC | Fidelity MSCI Health Care Index ETF | 13.8% | -27 bp | +1.9% |
Risk and Returns: XHE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 6/3/2026
Peer Group Comparison
Sample data. Subscribe for access.
Historical Valuation Trends Sample data. Subscribe for access.
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
4.1%
ALTAR SCORE™
29th
PERCENTILE
UNDERWEIGHT
ETFRC RATING
There are 1,399 funds in the US Equity category with an average
ALTAR Score™ of 5.3% and a standard deviation
of 2.1%. XHE's ALTAR Score™ is approximately -0.6 standard
deviations above the category average. This places XHE in the 29th percentile
among funds in the category.
Sell-Side Consensus
$102.79
PRICE TARGET
+31.8%
UPSIDE